Israel Englander’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.84M | Buy |
36,882
+1,964
| +6% | +$266K | ﹤0.01% | 2840 |
|
|
2026
Q1 | $4.46M | Buy |
34,918
+25,548
| +273% | +$3.19M | ﹤0.01% | 3081 |
|
|
2025
Q4 | $1.14M | Sell |
9,370
-65,355
| -87% | -$7.49M | ﹤0.01% | 4395 |
|
|
2025
Q3 | $7.49M | Sell |
74,725
-244,905
| -77% | -$22.1M | ﹤0.01% | 2699 |
|
|
2025
Q2 | $26.5M | Buy |
319,630
+127,235
| +66% | +$10.2M | 0.01% | 1309 |
|
|
2025
Q1 | $15.6M | Buy |
+192,395
| New | +$17.2M | 0.01% | 1767 |
|
|
2024
Q4 | – | Sell |
-145,836
| Closed | -$14.1M | – | 6529 |
|
|
2024
Q3 | $14.4M | Buy |
145,836
+122,347
| +521% | +$12M | 0.01% | 1855 |
|
|
2024
Q2 | $2.18M | Sell |
23,489
-287,503
| -92% | -$25.8M | ﹤0.01% | 3474 |
|
|
2024
Q1 | $29.5M | Sell |
310,992
-691,796
| -69% | -$64.2M | 0.01% | 1211 |
|
|
2023
Q4 | $89.5M | Buy |
1,002,788
+883,466
| +740% | +$65.6M | 0.04% | 471 |
|
|
2023
Q3 | $8.71M | Sell |
119,322
-272,989
| -70% | -$21.8M | ﹤0.01% | 2178 |
|
|
2023
Q2 | $32.6M | Buy |
392,311
+273,269
| +230% | +$22.9M | 0.02% | 1019 |
|
|
2023
Q1 | $9.07M | Sell |
119,042
-667,739
| -85% | -$55.4M | 0.01% | 2061 |
|
|
2022
Q4 | $65.3M | Buy |
786,781
+143,621
| +22% | +$11.6M | 0.04% | 598 |
|
|
2022
Q3 | $51M | Buy |
643,160
+406,618
| +172% | +$34.3M | 0.03% | 668 |
|
|
2022
Q2 | $17.6M | Sell |
236,542
-606,972
| -72% | -$45.6M | 0.01% | 1437 |
|
|
2022
Q1 | $75.8M | Buy |
843,514
+313,186
| +59% | +$28.9M | 0.04% | 467 |
|
|
2021
Q4 | $59.4M | Buy |
530,328
+201,276
| +61% | +$24.3M | 0.03% | 627 |
|
|
2021
Q3 | $41.4M | Buy |
329,052
+21,884
| +7% | +$2.82M | 0.02% | 745 |
|
|
2021
Q2 | $41.6M | Buy |
307,168
+78,732
| +34% | +$10.4M | 0.03% | 701 |
|
|
2021
Q1 | $31M | Buy |
228,436
+188,397
| +471% | +$28.2M | 0.02% | 767 |
|
|
2020
Q4 | $5.64M | Sell |
40,039
-51,266
| -56% | -$6.57M | ﹤0.01% | 2326 |
|
|
2020
Q3 | $10.2K | Sell |
91,305
-136,965
| -60% | -$15.4M | 0.01% | 1231 |
|
|
2020
Q2 | $25.6M | Buy |
228,270
+154,426
| +209% | +$15.2M | 0.04% | 603 |
|
|
2020
Q1 | $5.72M | Sell |
73,844
-24,829
| -25% | -$2.2M | 0.01% | 1236 |
|
|
2019
Q4 | $9.38M | Sell |
98,673
-145,554
| -60% | -$12.6M | 0.01% | 1432 |
|
|
2019
Q3 | $18.6M | Buy |
244,227
+224,519
| +1,139% | +$18.7M | 0.03% | 825 |
|
|
2019
Q2 | $1.73M | Buy |
+19,708
| New | +$1.68M | ﹤0.01% | 2494 |
|
|
2018
Q4 | – | Sell |
-4,449
| Closed | -$427K | – | 4237 |
|
|
2018
Q3 | $427K | Sell |
4,449
-1,426
| -24% | -$138K | ﹤0.01% | 3322 |
|
|
2018
Q2 | $559K | Buy |
+5,875
| New | +$540K | ﹤0.01% | 3112 |
|
|
2016
Q2 | – | Sell |
-398,272
| Closed | -$20.6M | – | 3648 |
|
|
2016
Q1 | $20.6M | Buy |
+398,272
| New | +$20.7M | 0.05% | 470 |
|
|
2015
Q4 | – | Sell |
-5,738
| Closed | -$357K | – | 3810 |
|
|
2015
Q3 | $357K | Buy |
+5,738
| New | +$452K | ﹤0.01% | 2827 |
|
|
2015
Q2 | – | Sell |
-33,231
| Closed | -$2.5M | – | 3917 |
|
|
2015
Q1 | $2.5M | Buy |
+33,231
| New | +$2.32M | ﹤0.01% | 1813 |
|
|
2014
Q2 | – | Sell |
-54,333
| Closed | -$2.58M | – | 3951 |
|
|
2014
Q1 | $2.58M | Buy |
+54,333
| New | +$2.78M | 0.01% | 1604 |
|
Other funds holding XBI
JFG
Israel Englander's XBI Position: Q2 2026 in Review
Israel Englander increased its State Street SPDR S&P Biotech ETF (XBI) stake by 5.6% in Q2 2026, buying an estimated $266K and bringing the position to 36,882 shares worth $5.84M. The position accounts for ﹤0.01% of the portfolio, ranked #2840.
Israel Englander first reported a position in XBI in Q1 2014 and has held it in 34 quarters since. The position peaked at $89.5M in Q4 2023. 931 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Israel Englander held 36,882 shares of State Street SPDR S&P Biotech ETF worth $5.84M as of Q2 2026.
- Israel Englander bought 1,964 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $266K.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2840 holding.
- Israel Englander first reported a position in State Street SPDR S&P Biotech ETF in Q1 2014 and has held it in 34 quarters since.
- Israel Englander's State Street SPDR S&P Biotech ETF position peaked at $89.5M in Q4 2023.
- 931 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.